Form D · Other Health Care
MEDVERSANT TECHNOLOGIES, L.L.C.
Los Angeles, CA · CIK 0001614599
Offering snapshot reported Aug 7, 2014 · SEC filing
- Reported sold
- $6.35M Offering amount: $10M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 12, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 7, 2014 | Initial | $6,350,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $270K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-222440
This amount is subject to increase upon funding of the remaining amount to be sold and upon issuance of membership interests pursuant to the engagement agreement between the parties.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| BA Securities, LLC | 153489 |
Source: Form D, filed Aug 7, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matthew Haddad | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
355 S. Grand Ave., Suite 1700
Los Angeles, CA, 90071
Los Angeles, CA, 90071